Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - linezolid 400mg;  ;   - film coated tablet - 400 mg - active: linezolid 400mg     excipient: carnauba wax hyprolose magnesium stearate maize starch opadry white ys-1-18202 powdered cellulose sodium starch glycolate

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - tozinameran 0.5 mg/ml equivalent to 30 µg/0.3ml dose;  ;  ;  ;  ; tozinameran 0.5 mg/ml equivalent to 30 µg/0.3 ml dose - concentrate for injection - 0.5 mg/ml - active: tozinameran 0.5 mg/ml equivalent to 30 µg/0.3ml dose         excipient: 1,2-distearoyl-sn-glycero-3-phosphocholine alc-0159 alc-0315 cholesterol dibasic sodium phosphate dihydrate monobasic potassium phosphate potassium chloride sodium chloride sucrose water for injection active: tozinameran 0.5 mg/ml equivalent to 30 µg/0.3 ml dose excipient: 1,2-distearoyl-sn-glycero-3-phosphocholine alc-0159 alc-0315 cholesterol dibasic sodium phosphate dihydrate hydrochloric acid monobasic potassium phosphate potassium chloride sodium chloride sodium hydroxide sucrose water for injection - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 12 years of age and older. the use of this vaccine should be in accordance with official recommendations.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - tozinameran 0.1 mg/ml equivalent to 30 µg/0.3ml dose;  ;  ;  ;   - suspension for injection - 0.1 mg/ml - active: tozinameran 0.1 mg/ml equivalent to 30 µg/0.3ml dose         excipient: 1,2-distearoyl-sn-glycero-3-phosphocholine alc-0159 alc-0315 cholesterol sucrose trometamol trometamol hydrochloride water for injection - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 12 years of age and older. the use of this vaccine should be in accordance with official recommendations.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ondansetron hydrochloride dihydrate 4.986mg equivalent to 4 mg ondansetron - film coated tablet - 4 mg - active: ondansetron hydrochloride dihydrate 4.986mg equivalent to 4 mg ondansetron excipient: hypromellose lactose magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water titanium dioxide triacetin - indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron tabs pfizer is also indicated for the prevention of post-operative nausea and vomiting.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ondansetron hydrochloride dihydrate 9.972mg equivalent to 8 mg ondansetron - film coated tablet - 8 mg - active: ondansetron hydrochloride dihydrate 9.972mg equivalent to 8 mg ondansetron excipient: lactose magnesium stearate microcrystalline cellulose opadry yellow 03k52033 pregelatinised maize starch purified water - indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron tabs pfizer is also indicated for the prevention of post-operative nausea and vomiting.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dinoprostone 0.4 mg/ml - vaginal gel - 1mg/3g - active: dinoprostone 0.4 mg/ml excipient: colloidal silicon dioxide triacetin

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dinoprostone 0.8 mg/ml - vaginal gel - 2mg/3g - active: dinoprostone 0.8 mg/ml excipient: colloidal silicon dioxide triacetin - prostin e2 is indicated for the induction of labour in term or near term women who have favourable induction features; and who have singleton pregnancy with a vertex position.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methotrexate 25 mg/ml (as methotrexate sodium) - solution for injection - 7.5 mg/0.3ml - active: methotrexate 25 mg/ml (as methotrexate sodium) excipient: sodium chloride sodium hydroxide water for injection - methotrexate may be of value in the symptomatic control of server, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatologic consultation.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ethinylestradiol 0.035mg (approx. 3% overage added);  ; norethisterone 1mg;  ;   - tablet - active: ethinylestradiol 0.035mg (approx. 3% overage added)   norethisterone 1mg     excipient: lactose monohydrate magnesium stearate maize starch povidone - contraception.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ethinylestradiol 0.035mg (approx. 3% overage added);  ; norethisterone 1mg;  ;   - tablet - active: ethinylestradiol 0.035mg (approx. 3% overage added)   norethisterone 1mg     excipient: lactose monohydrate magnesium stearate maize starch povidone lactose lactose monohydrate as the monohydrate magnesium stearate microcrystalline cellulose sunset yellow fcf as fd&c yellow #6 lake - contraception.